Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

466
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
466
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

583
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
583
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the scalpel: rare and experimental nonsurgical treatments for basal cell carcinoma.

Dermatology online journal·2026
Same author

Primary Cutaneous Cryptococcosis in Immunocompetent Patients: Recognition and Management.

American journal of clinical dermatology·2026
Same author

Occupational Risk of Sexually Transmitted Infections in Aesthetic Dermatology and Dermatologic Surgery: Evidence and Prevention.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Ramadan and isotretinoin initiation: When deferral is the ethical choice.

Journal of the American Academy of Dermatology·2026
Same author

Clinical Updates on Birt-Hogg-Dubé Syndrome and Atypical Presentations: Diagnosis and Management.

Dermatology practical & conceptual·2026
Same author

The ethics of commercializing surgical discards.

Journal of the American Academy of Dermatology·2026
Same journal

Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy.

American journal of clinical dermatology·2026
Same journal

Defining the Potential for Disease Modification in Atopic Dermatitis.

American journal of clinical dermatology·2026
Same journal

Atopic Dermatitis: New Targets and Emerging Systemic Therapies.

American journal of clinical dermatology·2026
Same journal

Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.

American journal of clinical dermatology·2026
Same journal

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

American journal of clinical dermatology·2026
Same journal

A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.

American journal of clinical dermatology·2026
See all related articles

Related Experiment Video

Updated: Apr 1, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Mal de Meleda: A Focused Review.

Caroline Perez1, Amor Khachemoune2,3

  • 1University of Nevada School of Medicine, Reno, NV, USA.

American Journal of Clinical Dermatology
|October 9, 2015
PubMed
Summary
This summary is machine-generated.

Mal de Meleda is a rare genetic skin disorder causing progressive palmoplantar keratoderma. Mutations in the SLURP-1 gene are implicated, affecting keratinocyte apoptosis and inflammation.

More Related Videos

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.7K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

43.2K

Related Experiment Videos

Last Updated: Apr 1, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.7K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

43.2K

Area of Science:

  • Dermatology
  • Genetics
  • Pathology

Background:

  • Mal de Meleda is a rare autosomal recessive palmoplantar keratoderma (PPK) affecting palms and soles.
  • It presents with progressive hyperkeratosis, often impacting hand and foot function.
  • Histology reveals hyperkeratosis, acanthosis, and dermal lymphocytic infiltrate.

Purpose of the Study:

  • To review the clinical, histological, and genetic aspects of Mal de Meleda.
  • To discuss differential diagnoses and current management strategies.
  • To highlight the role of SLURP-1 mutations in the disease pathogenesis.

Main Methods:

  • Literature review of Mal de Meleda cases and research.
  • Analysis of clinical and histological findings.
  • Examination of genetic data related to SLURP-1 mutations.

Main Results:

  • Identified characteristic transgrediens and progrediens hyperkeratosis patterns.
  • Confirmed association of Mal de Meleda with SLURP-1 gene mutations.
  • Noted lack of established management guidelines, with common treatments including oral acitretin and topical keratolytic therapy.

Conclusions:

  • Mal de Meleda is a distinct PPK subtype linked to SLURP-1 dysfunction.
  • Management is supportive, focusing on symptom control and genetic counseling.
  • Further research is needed due to the disease's rarity.